chr20-44622936-G-A
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000696038.1(ADA):n.*495C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000046   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.0000034   (  0   hom.  ) 
Consequence
 ADA
ENST00000696038.1 non_coding_transcript_exon
ENST00000696038.1 non_coding_transcript_exon
Scores
 2
 Splicing: ADA:  0.0005714  
 2
Clinical Significance
Conservation
 PhyloP100:  1.91  
Publications
0 publications found 
Genes affected
 ADA  (HGNC:186):  (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019] 
 PKIG  (HGNC:9019):  (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71). 
BP6
Variant 20-44622936-G-A is Benign according to our data. Variant chr20-44622936-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 536189.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ADA | NM_000022.4 | c.679-6C>T | splice_region_variant, intron_variant | Intron 7 of 11 | ENST00000372874.9 | NP_000013.2 | ||
| ADA | NM_001322051.2 | c.607-6C>T | splice_region_variant, intron_variant | Intron 6 of 10 | NP_001308980.1 | |||
| ADA | NM_001322050.2 | c.274-6C>T | splice_region_variant, intron_variant | Intron 6 of 10 | NP_001308979.1 | |||
| ADA | NR_136160.2 | n.771-6C>T | splice_region_variant, intron_variant | Intron 7 of 10 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ENST00000696038.1 | n.*495C>T | non_coding_transcript_exon_variant | Exon 7 of 9 | ENSP00000512344.1 | |||||
| ADA | ENST00000696038.1 | n.*495C>T | 3_prime_UTR_variant | Exon 7 of 9 | ENSP00000512344.1 | |||||
| ADA | ENST00000372874.9 | c.679-6C>T | splice_region_variant, intron_variant | Intron 7 of 11 | 1 | NM_000022.4 | ENSP00000361965.4 | |||
| ADA | ENST00000695995.1 | c.289-6C>T | splice_region_variant, intron_variant | Intron 4 of 8 | ENSP00000512318.1 | |||||
| ADA | ENST00000695991.1 | c.217-6C>T | splice_region_variant, intron_variant | Intron 3 of 7 | ENSP00000512314.1 | 
Frequencies
GnomAD3 genomes  0.0000460  AC: 7AN: 152250Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7
AN: 
152250
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000159  AC: 4AN: 251492 AF XY:  0.0000147   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
4
AN: 
251492
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000342  AC: 5AN: 1461894Hom.:  0  Cov.: 33 AF XY:  0.00000413  AC XY: 3AN XY: 727248 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
5
AN: 
1461894
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
3
AN XY: 
727248
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
33480
American (AMR) 
 AF: 
AC: 
1
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53420
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1112012
Other (OTH) 
 AF: 
AC: 
2
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.515 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000459  AC: 7AN: 152368Hom.:  0  Cov.: 33 AF XY:  0.0000403  AC XY: 3AN XY: 74512 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7
AN: 
152368
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
3
AN XY: 
74512
show subpopulations 
African (AFR) 
 AF: 
AC: 
7
AN: 
41586
American (AMR) 
 AF: 
AC: 
0
AN: 
15310
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68034
Other (OTH) 
 AF: 
AC: 
0
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.461 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency    Benign:1 
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Benign 
 dbscSNV1_RF 
 Benign 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.